Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07123467) titled 'Cannabidiol-Assisted Learning for Managing Generalized Anxiety Disorder' on Aug. 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Wayne State University
Condition:
Generalized Anxiety Disorder (GAD)
Anxiety Disorders
Intervention:
Drug: Low-Dose Cannabidiol
Drug: Placebo Matched to Moderate-Dose Cannabidiol
Drug: Moderate-Dose Cannabidiol
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: September...